These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23117502)

  • 1. Poor diet quality is associated with low CD4 count and anemia and predicts mortality among antiretroviral therapy-naive HIV-positive adults in Uganda.
    Rawat R; McCoy SI; Kadiyala S
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):246-53. PubMed ID: 23117502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Hematologic Status in Relation to Clinical Outcomes among HIV-Infected Adults from Uganda: A Prospective Cohort Study.
    Ezeamama AE; Guwatudde D; Sikorskii A; Kabagambe EK; Spelts R; Vahey G; Fenton JI; Fawzi WW
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29649107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
    Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
    Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food elimination, food substitution, and nutrient supplementation among ARV-exposed HIV-positive persons in southern Ghana.
    Laar AK; Lartey MY; Ankomah A; Okyerefo MPK; Ampah EA; Letsa DP; Nortey PA; Kwara A
    J Health Popul Nutr; 2018 Dec; 37(1):26. PubMed ID: 30509309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
    Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
    BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study.
    Owachi D; Akatukunda P; Nanyanzi DS; Katwesigye R; Wanyina S; Muddu M; Kawuma S; Kalema N; Kabugo C; Semitala FC
    BMC Infect Dis; 2024 Feb; 24(1):239. PubMed ID: 38388345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
    Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.
    Calkins KL; Chander G; Joshu CE; Visvanathan K; Fojo AT; Lesko CR; Moore RD; Lau B
    JAMA Oncol; 2020 Feb; 6(2):227-235. PubMed ID: 31804663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study.
    Harding BN; Whitney BM; Nance RM; Ruderman SA; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer KH; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
    BMC Infect Dis; 2020 Mar; 20(1):238. PubMed ID: 32197585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.
    Chi BH; Giganti M; Mulenga PL; Limbada M; Reid SE; Mutale W; Stringer JS
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):125-31. PubMed ID: 19546812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand.
    Fregonese F; Collins IJ; Jourdain G; Lecoeur S; Cressey TR; Ngo-Giang-Houng N; Banchongkit S; Chutanunta A; Techapornroong M; Lallemant M;
    J Acquir Immune Defic Syndr; 2012 May; 60(1):91-8. PubMed ID: 22293548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of Anemia Types During Antiretroviral Therapy-Implications for Treatment Outcomes and Quality of Life Among HIV-Infected Adults.
    Ezeamama AE; Sikorskii A; Bajwa RK; Tuke R; Kyeyune RB; Fenton JI; Guwatudde D; Fawzi WW
    Nutrients; 2019 Mar; 11(4):. PubMed ID: 30935133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa.
    Hoffmann CJ; Schomaker M; Fox MP; Mutevedzi P; Giddy J; Prozesky H; Wood R; Garone DB; Egger M; Boulle A;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):34-41. PubMed ID: 23344547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
    Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
    AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    ; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
    Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    Wandera B; Tumwesigye NM; Nankabirwa JI; Kambugu AD; Mafigiri DK; Kapiga S; Sethi AK
    PLoS One; 2017; 12(6):e0180015. PubMed ID: 28665974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trial.
    Woodd SL; Grosskurth H; Levin J; Amuron B; Namara G; Birunghi J; Coutinho A; Jaffar S
    AIDS; 2014 Feb; 28(4):569-76. PubMed ID: 24468997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.